Return on Assets: An indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets. Calculated as: Income from Continuing Operations / Total Assets
Basilea Pharmaceutica AG (BPMUF) had Return on Assets of 30.10% for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
$236.88M |
|
$88.14M |
|
$43.94M |
|
$192.95M |
|
$167.39M |
|
$69.49M |
|
$-1.04M |
|
$68.45M |
|
$68.45M |
|
$88.14M |
|
$88.14M |
|
$88.14M |
|
$88.14M |
|
$69.49M |
|
$71.46M |
|
12.09M |
|
13.86M |
|
$7.29 |
|
$6.62 |
|
| Balance Sheet Financials | |
$250.93M |
|
$4.55M |
|
$41.86M |
|
$292.79M |
|
$51.75M |
|
$108.95M |
|
$149.04M |
|
$200.79M |
|
$92.01M |
|
$91.58M |
|
$92.01M |
|
11.05M |
|
| Cash Flow Statement Financials | |
$84.47M |
|
$-1.15M |
|
$-14.95M |
|
$73.06M |
|
$141.49M |
|
$68.42M |
|
$5.75M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.85 |
|
-- |
|
-- |
|
0.54 |
|
1.18 |
|
81.45% |
|
29.34% |
|
29.34% |
|
30.17% |
|
28.90% |
|
37.21% |
|
$82.53M |
|
-- |
|
-- |
|
-- |
|
0.81 |
|
1.22 |
|
3.58 |
|
101.83 |
|
95.79% |
|
96.24% |
|
|
Return on Assets |
30.10% |
43.86% |
|
$8.33 |
|
$5.96 |
|
$6.10 |
|